Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YD02-2022 in Brittle Type 1 Diabetes
NCT05990530Phase 2Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Feb 2023
- Primary completion
- Aug 2024
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of YD02-2022 in type 1 diabetes mellitus (T1D), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
YD02-2022
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05990530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05990530.